Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Mar;57(3):326–331. doi: 10.1038/bjc.1988.74

Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men.

G D Honda 1, L Bernstein 1, R K Ross 1, S Greenland 1, V Gerkins 1, B E Henderson 1
PMCID: PMC2246522  PMID: 3355774

Abstract

A population-based case-control study was conducted in men aged 60 or less to assess the risk of prostate cancer associated with vasectomy and other factors. Data were obtained from 216 case-control pairs by telephone interviews; this number represented 55% of all eligible cases. The matched pairs relative risk (RR) for vasectomy in ever married men was 1.4 with a 95% confidence interval (CI) of 0.9-2.3. There was a positive association between the number of years since vasectomy and prostate cancer risk (1-sided P = 0.01). Early age at first sexual intercourse was associated with increased prostate cancer risk (age less than 17 vs. 21+, RR = 2.3, 95% CI = 1.3, 4.0) but there were no consistent associations with number of sexual partners or frequency of sexual intercourse. Cigarette smoking was also associated with increased risk of prostate cancer (RR = 1.9, 95% CI = 1.2, 3.0) and there was a positive dose-response relationship with years of smoking (1-sided P = 0.001). We discuss the possible implication of the low response rate on each of these findings. To determine whether the association with vasectomy might have a hormonal basis, we compared levels of testosterone (T) and testosterone binding globulin-binding capacity (TeBG-bc) in 33 of the vasectomized control men with levels in 33 non-vasectomized controls of the same age, weight and height. T levels were higher in vasectomized than in non-vasectomized controls (1-sided P = 0.06). The ratio of T to TeBG-bc (an index of bioavailable T) was 13.5% higher in vasectomized men (1-sided P = 0.03).

Full text

PDF
329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahluwalia B., Jackson M. A., Jones G. W., Williams A. O., Rao M. S., Rajguru S. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer. 1981 Nov 15;48(10):2267–2273. doi: 10.1002/1097-0142(19811115)48:10<2267::aid-cncr2820481023>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  2. Armenian H. K., Lilienfeld A. M., Diamond E. L., Bross I. D. Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol. 1975 Jul;102(1):47–54. doi: 10.1093/oxfordjournals.aje.a112133. [DOI] [PubMed] [Google Scholar]
  3. Armenian H. K., Lilienfeld A. M., Diamond E. L., Bross I. D. Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet. 1974 Jul 20;2(7873):115–117. doi: 10.1016/s0140-6736(74)91551-7. [DOI] [PubMed] [Google Scholar]
  4. Dai W. S., Kuller L. H., LaPorte R. E., Gutai J. P., Falvo-Gerard L., Caggiula A. The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol. 1981 Dec;114(6):804–816. doi: 10.1093/oxfordjournals.aje.a113251. [DOI] [PubMed] [Google Scholar]
  5. Deslypere J. P., Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab. 1984 Nov;59(5):955–962. doi: 10.1210/jcem-59-5-955. [DOI] [PubMed] [Google Scholar]
  6. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drafta D., Proca E., Zamfir V., Schindler A. E., Neacşu E., Stroe E. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J Steroid Biochem. 1982 Dec;17(6):689–693. doi: 10.1016/0022-4731(82)90572-6. [DOI] [PubMed] [Google Scholar]
  8. Furuyama S., Mayes D. M., Nugent C. A. A radioimmunoassay for plasma testosterone. Steroids. 1970 Oct;16(4):415–428. doi: 10.1016/s0039-128x(70)80124-6. [DOI] [PubMed] [Google Scholar]
  9. Ghanadian R., Puah C. M., O'Donoghue E. P. Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer. 1979 Jun;39(6):696–699. doi: 10.1038/bjc.1979.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greenwald P., Kirmss V., Polan A. K., Dick V. S. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst. 1974 Aug;53(2):335–340. doi: 10.1093/jnci/53.2.335. [DOI] [PubMed] [Google Scholar]
  11. Gupta A. S., Kothari L. K., Bapna R. B. Surgical sterilization by vasectomy and its effects on the structure and function of the testis in man. Br J Surg. 1975 Jan;62(1):59–63. doi: 10.1002/bjs.1800620114. [DOI] [PubMed] [Google Scholar]
  12. Hammond E. C. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr. 1966 Jan;19:127–204. [PubMed] [Google Scholar]
  13. Henderson B. E., Gordon R. J., Menck H., Soohoo J., Martin S. P., Pike M. C. Lung cancer and air pollution in southcentral Los Angeles County. Am J Epidemiol. 1975 Jun;101(6):477–488. doi: 10.1093/oxfordjournals.aje.a112118. [DOI] [PubMed] [Google Scholar]
  14. Heshmat M. Y., Kovi J., Herson J., Jones G. W., Jackson M. A. Epidemiologic association between Gonorrhea and prostatic carcinoma. Urology. 1975 Oct;6(4):457–460. doi: 10.1016/0090-4295(75)90627-5. [DOI] [PubMed] [Google Scholar]
  15. Jackson M. A., Kovi J., Heshmat M. Y., Ogunmuyiwa T. A., Jones G. W., Williams A. O., Christian E. C., Nkposong E. O., Rao M. S., Jackson A. G. Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate. 1980;1(2):185–205. doi: 10.1002/pros.2990010205. [DOI] [PubMed] [Google Scholar]
  16. Johnsonbaugh R. E., O'Connell K., Engel S. B., Edson M., Sode J. Plasma testosterone, luteinizing hormone, and follicle-stimulating hormone after vasectomy. Fertil Steril. 1975 Apr;26(4):329–330. [PubMed] [Google Scholar]
  17. Kinson G. A., Layberry R. A. Long-term endocrine responses to vasectomy in the adult rat. Contraception. 1975 Feb;11(2):143–150. doi: 10.1016/0010-7824(75)90024-4. [DOI] [PubMed] [Google Scholar]
  18. Krain L. S. Some epidemiologic variables in prostatic carcinoma in California. Prev Med. 1974 Mar;3(1):154–159. doi: 10.1016/0091-7435(74)90070-x. [DOI] [PubMed] [Google Scholar]
  19. Mack T. M. Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr. 1977 Dec;47:99–101. [PubMed] [Google Scholar]
  20. Mishina T., Watanabe H., Araki H., Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate. 1985;6(4):423–436. doi: 10.1002/pros.2990060411. [DOI] [PubMed] [Google Scholar]
  21. Naik V. K., Joshi U. M., Sheth A. R. Long-term effects of vasectomy on prostatic function in men. J Reprod Fertil. 1980 Mar;58(2):289–293. doi: 10.1530/jrf.0.0580289. [DOI] [PubMed] [Google Scholar]
  22. Nankin H. R., Pinto R., Fan D. F., Troen P. Daytime titers of testosterone, LH, estrone, estradiol, and testosterone-binding protein: acute effects of LH and LH-releasing hormone in men. J Clin Endocrinol Metab. 1975 Aug;41(2):271–281. doi: 10.1210/jcem-41-2-271. [DOI] [PubMed] [Google Scholar]
  23. Noble R. L. Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol. 1982;23:113–159. [PubMed] [Google Scholar]
  24. Pierrepoint C. G., Davies P. The effect of vasectomy on the activity of prostatic RNA polymerase in rats. J Reprod Fertil. 1973 Oct;35(1):149–152. doi: 10.1530/jrf.0.0350149. [DOI] [PubMed] [Google Scholar]
  25. Purvis K., Saksena S. K., Cekan Z., Diczfalusy E., Giner J. Endocrine effects of vasectomy. Clin Endocrinol (Oxf) 1976 May;5(3):263–272. doi: 10.1111/j.1365-2265.1976.tb01952.x. [DOI] [PubMed] [Google Scholar]
  26. Ross R. K., Deapen D. M., Casagrande J. T., Paganini-Hill A., Henderson B. E. A cohort study of mortality from cancer of the prostate in Catholic priests. Br J Cancer. 1981 Feb;43(2):233–235. doi: 10.1038/bjc.1981.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ross R. K., Paganini-Hill A., Henderson B. E. The etiology of prostate cancer: what does the epidemiology suggest? Prostate. 1983;4(4):333–344. doi: 10.1002/pros.2990040403. [DOI] [PubMed] [Google Scholar]
  28. Ross R., Bernstein L., Judd H., Hanisch R., Pike M., Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst. 1986 Jan;76(1):45–48. [PubMed] [Google Scholar]
  29. Sheth A. R., Panse G. T. Can vasectomy reduce the incidence of prostatic tumor? Med Hypotheses. 1982 Mar;8(3):237–241. doi: 10.1016/0306-9877(82)90118-9. [DOI] [PubMed] [Google Scholar]
  30. Skegg D. C., Mathews J. D., Guillebaud J., Vessey M. P., Biswas S., Ferguson K. M., Kitchin Y., Mansfield M. D., Sommerville I. F. Hormonal assessment before and after vasectomy. Br Med J. 1976 Mar 13;1(6010):621–622. doi: 10.1136/bmj.1.6010.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steele R., Lees R. E., Kraus A. S., Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis. 1971 Jun;24(1):29–37. doi: 10.1016/0021-9681(71)90056-7. [DOI] [PubMed] [Google Scholar]
  32. Tsitouras P. D., Martin C. E., Harman S. M. Relationship of serum testosterone to sexual activity in healthy elderly men. J Gerontol. 1982 May;37(3):288–293. doi: 10.1093/geronj/37.3.288. [DOI] [PubMed] [Google Scholar]
  33. Udry J. R., Billy J. O., Morris N. M., Groff T. R., Raj M. H. Serum androgenic hormones motivate sexual behavior in adolescent boys. Fertil Steril. 1985 Jan;43(1):90–94. [PubMed] [Google Scholar]
  34. Uehling D. T., Wear J. B. Patient attitudes towards vasectomy. Fertil Steril. 1972 Nov;23(11):838–840. doi: 10.1016/s0015-0282(16)39316-5. [DOI] [PubMed] [Google Scholar]
  35. Varma M. M., Varma R. R., Johanson A. J., Kowarski A., Migeon C. J. Long-term effects of vasectomy on pituitary-gonadal function in man. J Clin Endocrinol Metab. 1975 May;40(5):868–871. doi: 10.1210/jcem-40-5-868. [DOI] [PubMed] [Google Scholar]
  36. WOOLF C. M. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 1960 Jul-Aug;13:739–744. doi: 10.1002/1097-0142(196007/08)13:4<739::aid-cncr2820130414>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  37. Wynder E. L., Mabuchi K., Whitmore W. F., Jr Epidemiology of cancer of the prostate. Cancer. 1971 Aug;28(2):344–360. doi: 10.1002/1097-0142(197108)28:2<344::aid-cncr2820280214>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  38. de la Torre B., Hedman M., Jensen F., Pedersen P. H., Diczfalusy E. Lack of effect of vasectomy on peripheral gonadotrophin and steroid levels. Int J Androl. 1983 Apr;6(2):125–134. doi: 10.1111/j.1365-2605.1983.tb00331.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES